TNIP1 and endothelial dysfunction: The reduction of TNIP1 relieves the inhibition of the NFκB signaling pathway, resulting in elevated levels of inflammatory factors (e.g., IL-1β and IL-18) and exacerbating retinal vascular inflammation and endothelial dysfunction [88].